Oncopharmpod
Q 6 Pembro, PARP Inhibitors, MonarcHER, Griffin
- Author: Vários
- Narrator: Vários
- Publisher: Podcast
- Duration: 0:25:14
- More information
Informações:
Synopsis
Topics of discussion: Q 6 week pembrolizumab dosing schedule FDA approved Updates on possible PARP inhibitor use. Niraparib for ovarian maintenance. Olaparib in prostate cancer (5:28) The monarcHER study of abemaciclib in HER+ MBC (12:20) The GRIFFIN study of Dara+VRD in myeloma (17:00)
